New data suggests that retatrutide, a novel medication, could represent a major advance in size management. This therapy combines the actions of a GLP-1 receptor and a GIP agonist , seemingly offering a https://socialbuzzfeed.com/story7181026/this-new-breakthrough-for-weight-control